Tyrosine-protein phosphatase non-receptor type 11
| GO Term | Evidence Code | Reference |
|---|---|---|
| DNA damage checkpoint signaling |
|
|
| triglyceride metabolic process |
|
|
| epidermal growth factor receptor signaling pathway | ||
| integrin-mediated signaling pathway |
|
|
| axonogenesis |
|
|
| GO Term | Evidence Code | Reference |
|---|---|---|
| phosphotyrosine residue binding | ||
| phosphoprotein phosphatase activity | ||
| phosphoprotein phosphatase activity | ||
| protein tyrosine phosphatase activity | ||
| protein tyrosine phosphatase activity |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 566 |
|
|
| Pathway Name | Organism |
|---|---|
| Activated NTRK2 signals through FRS2 and FRS3 | Homo sapiens |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | Homo sapiens |
| Co-inhibition by BTLA | Homo sapiens |
| Co-inhibition by CTLA4 | Homo sapiens |
| Constitutive Signaling by Aberrant PI3K in Cancer | Homo sapiens |
| Downstream signal transduction | Homo sapiens |
| FLT3 Signaling | Homo sapiens |
| FRS-mediated FGFR1 signaling | Homo sapiens |
| FRS-mediated FGFR2 signaling | Homo sapiens |
| FRS-mediated FGFR3 signaling | Homo sapiens |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:2602 | chondroma | |
| DOID:0050458 | juvenile myelomonocytic leukemia | |
| DOID:0080548 | Noonan syndrome with multiple lentigines 1 | |
| DOID:6419 | tetralogy of Fallot | |
| DOID:8929 | atrophic gastritis | |
| DOID:0060578 | Noonan syndrome 1 | |
| DOID:0111512 | metachondromatosis | |
| DOID:10534 | stomach cancer | |
| DOID:3490 | Noonan syndrome |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026